Interdisciplinary Compassionate Care
Innovative Cancer Research
Cancer Care
Your hub for all medical oncology clinical offerings, including current clinical trials, the CARE clinic, and how to find a provider or specialty care location in your area.
Find Care Near You →Education
Our faculty remain dedicated to developing future world leaders in academic cancer medicine through comprehensive training programs.
Explore Our Programs →Research
Meet our clinicians and laboratory researchers and learn more about the novel and exciting strides being made in cancer research.
Discover Our Research →Newsroom
Explore stories that highlight the innovative research and clinical advances our faculty are making in the field of oncology.
Find Stories →dc0d0ae9302864d9a5bfff02001ce385.png?sfvrsn=13256eb5_0)
d86806e9302864d9a5bfff02001ce385.png?sfvrsn=174062b5_0)
By the Numbers
faculty
researchers
cancer publications
peer-reviewed funding
Medical Oncology Newsroom
.png?sfvrsn=681773b5_1 "Website Photo Squares (33)")
Breast Cancer Discovery Moves Closer to First In-Human Clinical Trial
Traci Lyons, Phd, and Virginia Borges, MD, MMSc are evaluating Pearl-01, an antibody that targets the protein semaphorin 7A, in advance of a first-in-human clinical trial.
.png?sfvrsn=d94b62b5_1 "Website Photo Squares (24)")
FDA Clears Clinical Trial Uses CAR T-Cells to Fight Colorectal Cancer
Developed at CU Anschutz, the therapy targets two pathways that help tumors grow and evade the immune system. The trial will assess the therapy’s safety and ability to attack cancer in patients.
.png?sfvrsn=91060b5_1 "Website Photo Squares (18)")
Game-Changing Clinical Trials for Advanced Prostate Cancer Underway
Laura Graham, MD, is the site PI for the potentially game changing immunotherapy drug trials of a bispecific T-cell engager that links a protein on a T cell with a protein on the tumor.
.png?sfvrsn=9cb4ddb4_1 "Website Photo Squares (9)")
Dr. Wood Receives Grant to Improve Cancer Prevention and Survivorship
Through a five-year grant, oncologist Marie Wood, MD, aims to promote clinical trials that are focused on preventing cancer and improving outcomes for survivors.